Massachusetts General Hospital Cancer Center is honoring ITA Senior Scientist Carrie Lubitz, MD, MPH as one of "The One Hundred" for 2017.
Created and supported by the Massachusetts General Hospital Cancer Center, the one hundred is an awareness and fundraising initiative that celebrates hope in the cancer community. Honored each year are 100 Everyday Amazing individuals and groups — caregivers, researchers, philanthropists, advocates and volunteers from around the globe —who are taking action in the fight against cancer in inspiring and often revolutionary ways. Honorees are selected through a public nomination process and this celebration this year takes place on June 15th at the Westin Boston Waterfront Hotel.
From the article:
Through her clinical and translational research efforts, Carrie Lubitz, MD, MPH, is influencing thyroid cancer care across the world.
Dr. Lubitz has placed a high priority on prediction and decision-analytic modeling. This, in turn, has helped to assess the comparative effectiveness and improve the quality of care of patients with endocrine-related disorders. Her focus on this area is exceedingly important, as it underscores the need for cancer care to be closely aligned with the specific needs of each patient.
To read more, visit https://www.theonehundred.org/honorees/carrie-c-lubitz-md-mph/